These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34114732)

  • 41. Effects of Previous or Synchronous Non-Muscle Invasive Bladder Cancer on Clinical Results after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multi-Institutional Study.
    Kim BW; Ha YS; Lee JN; Kim HT; Kim TH; Lee JK; Byun SS; Choi YD; Kang HW; Yun SJ; Kim WJ; Kwon YS; Kwon TG
    Urol J; 2015 Sep; 12(4):2233-9. PubMed ID: 26341764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic Review on the Fate of the Remnant Urothelium after Radical Cystectomy.
    Gakis G; Black PC; Bochner BH; Boorjian SA; Stenzl A; Thalmann GN; Kassouf W
    Eur Urol; 2017 Apr; 71(4):545-557. PubMed ID: 27720534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A clinical study of associated bladder tumor in patients with renal pelvic and ureteral tumor].
    Sugano O; Shouji N; Horigome T; Uchi K; Katou H
    Nihon Hinyokika Gakkai Zasshi; 1995 Aug; 86(8):1383-7. PubMed ID: 7474623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin.
    Hemminki K; Dong C
    Arch Dermatol; 2000 May; 136(5):647-51. PubMed ID: 10815858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
    Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
    Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: a single institutional retrospective long-term follow-up study.
    Takaoka E; Hinotsu S; Joraku A; Oikawa T; Sekido N; Miyanaga N; Kawai K; Shimazui T; Akaza H
    Int J Urol; 2010 Jul; 17(7):623-8. PubMed ID: 20412341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers.
    Zheng G; Sundquist K; Sundquist J; Chen T; Försti A; Hemminki A; Liska V; Hemminki K
    Clin Epidemiol; 2021; 13():683-691. PubMed ID: 34377034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Hagiwara M; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Hasegawa S; Nakajima Y; Oya M
    Ann Surg Oncol; 2014 Sep; 21(9):3151-8. PubMed ID: 24682698
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Concurrent renal cell carcinoma and urothelial carcinoma: long-term follow-up study of 24 cases].
    Qi NN; Li T; Ning XH; Chen JC; Cai L; Gong K
    Zhonghua Yi Xue Za Zhi; 2017 Mar; 97(12):940-943. PubMed ID: 28355757
    [No Abstract]   [Full Text] [Related]  

  • 50. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects.
    Liu H; Hemminki K; Sundquist J; Holleczek B; Katalinic A; Emrich K; Jansen L; Brenner H;
    Cancer Med; 2013 Oct; 2(5):718-24. PubMed ID: 24403237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan.
    Huang PC; Huang CY; Huang SW; Lai MK; Yu HJ; Chen J; Pu YS
    Int J Urol; 2006 Jul; 13(7):864-9. PubMed ID: 16882044
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract.
    Strong DW; Pearse HD
    Cancer; 1976 Nov; 38(5):2173-83. PubMed ID: 991130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does Ureteral Stenting Increase the Risk of Metachronous Upper Tract Urothelial Carcinoma in Patients with Bladder Tumors? A Systematic Review and Meta-analysis.
    Sountoulides P; Pyrgidis N; Brookman-May S; Mykoniatis I; Karasavvidis T; Hatzichristou D
    J Urol; 2021 Apr; 205(4):956-966. PubMed ID: 33284711
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinicopathological characteristics of muscle-invasive bladder recurrence in upper tract urothelial carcinoma.
    Shigeta K; Matsumoto K; Ogihara K; Murakami T; Anno T; Umeda K; Izawa M; Baba Y; Sanjo T; Shojo K; Tanaka N; Takeda T; Kosaka T; Mizuno R; Mikami S; Kikuchi E; Oya M
    Cancer Sci; 2021 Mar; 112(3):1084-1094. PubMed ID: 33368857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metachronous bladder tumors in patients with upper urinary tract transitional cell carcinoma.
    Mukamel E; Simon D; Edelman A; Konichezky M; Hadar H; Servadio C
    J Surg Oncol; 1994 Nov; 57(3):187-90. PubMed ID: 7967608
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The risk of second malignancies after
    Fernandez Ots A; Browne L; Chin YS; Malouf D; Wong K; Bucci J
    Brachytherapy; 2016; 15(6):752-759. PubMed ID: 27475483
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study.
    Lal G; Groff M; Howe JR; Weigel RJ; Sugg SL; Lynch CF
    Ann Surg Oncol; 2012 Jun; 19(6):1887-96. PubMed ID: 22227921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma.
    Tai YS; Chen CH; Huang CY; Tai HC; Wang SM; Pu YS
    Diabetes Metab Res Rev; 2015 Mar; 31(3):307-14. PubMed ID: 25363092
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
    Chattopadhyay S; Sud A; Zheng G; Yu H; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
    Int J Cancer; 2018 Nov; 143(10):2449-2457. PubMed ID: 30238973
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinicopathological study on upper urinary tract tumors and associated bladder tumors.
    Nishimura K; Shimizu K; Iwasaki A; Miyoshi S; Mizutani S
    Urol Int; 1995; 55(3):128-33. PubMed ID: 8540154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.